Video

Dr. Goy on the Importance of Refined Decision Making With Precision Medicine

Andre H. Goy, MD, discusses the importance of refined decision making with precision medicine.

Andre H. Goy, MD, Physician in Chief Hackensack Meridian Health Oncology Care Transformation Service, Chairman & Chief Physician Officer - John Theurer Cancer Center, Lydia Pfund Chair for Lymphoma, Academic Chairman Oncology - Hackensack Meridian School of Medicine, Professor of Medicine – Georgetown University, Hackensack, NJ, discusses the importance of refined decision making with precision medicine. 

When looking at precision medicine, it is important to have one consistent definition, Goy says. Precision medicine is not a new concept, as it was first utilized in the 19th century, and has been expanding rapidly in recent years, Goy explains. The misconception of precision medicine is that treatment can be personalized to each individual patient; however, treatment decisions are informed by available clinical and molecular data that allow for the refinement and optimization of treatment options, Goy notes.

To implement precision medicine strategies, it is important to organize all available knowledge and data to then apply it to clinical practice, optimize treatment, and provide patients with the best possible outcome, Goy concludes. 

Related Videos
Albert Grinshpun, MD, MSc, head, Breast Oncology Service, Shaare Zedek Medical Center
Erica L. Mayer, MD, MPH, director, clinical research, Dana-Farber Cancer Institute; associate professor, medicine, Harvard Medical School
Stephanie Graff, MD, and Chandler Park, FACP
Mariya Rozenblit, MD, assistant professor, medicine (medical oncology), Yale School of Medicine
Maxwell Lloyd, MD, clinical fellow, medicine, Department of Medicine, Beth Israel Deaconess Medical Center
Neil Iyengar, MD, and Chandler Park, MD, FACP
Azka Ali, MD, medical oncologist, Cleveland Clinic Taussig Cancer Institute
Rena Callahan, MD, and Chandler Park, MD, FACP
Hope S. Rugo, MD, FASCO, Winterhof Family Endowed Professor in Breast Cancer, professor, Department of Medicine (Hematology/Oncology), director, Breast Oncology and Clinical Trials Education; medical director, Cancer Infusion Services; the University of California San Francisco Helen Diller Family Comprehensive Cancer Center
Virginia Kaklamani, MD, DSc, professor, medicine, Division of Hematology-Medical Oncology, The University of Texas (UT) Health Science Center San Antonio; leader, breast cancer program, Mays Cancer Center, UT Health San Antonio MD Anderson Cancer Center